Clinical Trial Update: Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether aldosterone inhibition reduces myocardial diffuse fibrosis to prevent recurrent atrial fibrillation in patients with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Svendborg Hospital | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN